Dynatrace trades at a significant valuation discount to Datadog despite strong revenue, earnings, and free cash flow growth. DT’s net revenue retention remains above 110%, and margins are stable, ...

Cloud partnerships are fueling Dynatrace's growth. Dynatrace is buying back its shares as its free cash flow swells. Dynatrace's revenue jumped 18% year over year to $515 million in its fiscal 2026 ...

Cloud observability platform Dynatrace (NYSE:DT) will be reporting results this Monday before the bell. Here’s what to look for. Dynatrace beat analysts’ revenue expectations by 1.3% last quarter, ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Dynatrace (DT) is in focus after its Perform 2026 conference, where management ...

Artificial intelligence observability platform company Dynatrace Inc. today announced a set of platform updates at its Perform Conference in Las Vegas that included the debut of Dynatrace Intelligence ...

Dynatrace (NYSE:DT) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ...

With college football's regular season over and conference championships decided, an interesting bowl season is just around the corner. The second season of the 12-team College Football Playoff format ...

For years, SEOs optimized pages around keywords. But Google now understands meaning through entities and how they relate to one another: people, products, concepts, and their topical connections ...

Dynatrace Inc. (NYSE:DT) shares rose Wednesday after the company topped second-quarter earnings and revenue forecasts and lifted its fiscal 2026 outlook. The company reported adjusted earnings of 44 ...

On Tuesday, just one week after launching short-term streaming passes, Sling began offering another new service: Sling Select. At just $19.99 per month, Select is one of the most affordable ways to ...

MALAGA, Spain—Clinicians caring for patients with obesity or overweight and established cardiovascular disease should start patients on semaglutide (Wegovy; Novo Nordisk) as soon as possible. That’s ...